Typicality: | 0.549 |
Saliency: | 0.346 |
with receiving the drug | 5 | other |
in total | 2 | other |
according to the inclusion criteria | 2 | other |
subject → complete → the trial | 37 |
subject → complete → trial | 6 |
negative | neutral | positive |
0.094 | 0.744 | 0.162 |
Raw frequency | 43 |
Normalized frequency | 0.346 |
Modifier score | 0.967 |
Perplexity | 34.208 |